Natalie Hyppolite, DO | |
525 Branson Landing Blvd Ste 400, Branson, MO 65616-2052 | |
(417) 330-3480 | |
(417) 330-3485 |
Full Name | Natalie Hyppolite |
---|---|
Gender | Female |
Speciality | Physical Medicine And Rehabilitation |
Experience | 11 Years |
Location | 525 Branson Landing Blvd Ste 400, Branson, Missouri |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831535798 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 2019029226 (Missouri) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Post-acute Physicians Of Missouri, Pc | 6002121126 | 14 |
News Archive
ChromaDex Corp. announced today that the initial results of the first human clinical study for the company's NIAGEN nicotinamide riboside (NR) has met its primary endpoint.
Life Technologies Corporation today announced that its scientists have teamed with researchers from Stanford University School of Medicine, and other institutions to discover a genomic component that plays a key role in promoting breast cancer progression. A study published today in the journal Nature details how levels of a specific kind of non-coding RNA molecule in primary breast tumors regulate metastasis and tumor invasiveness and may be an important target for cancer diagnosis and therapy.
News outlets examine a variety of issues related to the health law's implementation, ranging from how it might impact workers in the year ahead, to those who will not gain any benefit from the law as well as the importance of location and other news about how the overhaul will affect the health care marketplace.
Today's headlines include a range of stories about the implementation of the health law and related policy developments.
› Verified 9 days ago
Entity Name | Post-acute Physicians Of Missouri, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1164818290 PECOS PAC ID: 6002121126 Enrollment ID: O20150819007678 |
News Archive
ChromaDex Corp. announced today that the initial results of the first human clinical study for the company's NIAGEN nicotinamide riboside (NR) has met its primary endpoint.
Life Technologies Corporation today announced that its scientists have teamed with researchers from Stanford University School of Medicine, and other institutions to discover a genomic component that plays a key role in promoting breast cancer progression. A study published today in the journal Nature details how levels of a specific kind of non-coding RNA molecule in primary breast tumors regulate metastasis and tumor invasiveness and may be an important target for cancer diagnosis and therapy.
News outlets examine a variety of issues related to the health law's implementation, ranging from how it might impact workers in the year ahead, to those who will not gain any benefit from the law as well as the importance of location and other news about how the overhaul will affect the health care marketplace.
Today's headlines include a range of stories about the implementation of the health law and related policy developments.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Natalie Hyppolite, DO Po Box 802843, Kansas City, MO 64180-2843 Ph: (417) 730-6430 | Natalie Hyppolite, DO 525 Branson Landing Blvd Ste 400, Branson, MO 65616-2052 Ph: (417) 330-3480 |
News Archive
ChromaDex Corp. announced today that the initial results of the first human clinical study for the company's NIAGEN nicotinamide riboside (NR) has met its primary endpoint.
Life Technologies Corporation today announced that its scientists have teamed with researchers from Stanford University School of Medicine, and other institutions to discover a genomic component that plays a key role in promoting breast cancer progression. A study published today in the journal Nature details how levels of a specific kind of non-coding RNA molecule in primary breast tumors regulate metastasis and tumor invasiveness and may be an important target for cancer diagnosis and therapy.
News outlets examine a variety of issues related to the health law's implementation, ranging from how it might impact workers in the year ahead, to those who will not gain any benefit from the law as well as the importance of location and other news about how the overhaul will affect the health care marketplace.
Today's headlines include a range of stories about the implementation of the health law and related policy developments.
› Verified 9 days ago
Dr. Nicholas Robert Anderson, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 525 Branson Landing Blvd Ste 400, Branson, MO 65616 Phone: 417-330-3480 Fax: 417-330-3485 |